ANI Pharmaceuticals Inc (ANIP)
65.45
+0.86
(+1.33%)
USD |
NASDAQ |
Apr 19, 16:00
65.45
0.00 (0.00%)
After-Hours: 18:10
ANI Pharmaceuticals Gross Profit Margin (Quarterly): 59.42% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 59.42% |
| September 30, 2023 | 63.51% |
| June 30, 2023 | 63.72% |
| March 31, 2023 | 64.69% |
| December 31, 2022 | 61.45% |
| September 30, 2022 | 60.76% |
| June 30, 2022 | 52.21% |
| March 31, 2022 | 46.85% |
| December 31, 2021 | 44.36% |
| September 30, 2021 | 53.11% |
| June 30, 2021 | 54.11% |
| March 31, 2021 | 63.34% |
| December 31, 2020 | 57.14% |
| September 30, 2020 | 62.03% |
| June 30, 2020 | 57.30% |
| March 31, 2020 | 56.19% |
| December 31, 2019 | 62.90% |
| September 30, 2019 | 70.78% |
| June 30, 2019 | 71.24% |
| March 31, 2019 | 72.16% |
| December 31, 2018 | 64.75% |
| September 30, 2018 | 69.22% |
| June 30, 2018 | 64.90% |
| March 31, 2018 | 55.48% |
| December 31, 2017 | 56.76% |
| Date | Value |
|---|---|
| September 30, 2017 | 56.24% |
| June 30, 2017 | 52.81% |
| March 31, 2017 | 55.26% |
| December 31, 2016 | 55.75% |
| September 30, 2016 | 56.73% |
| June 30, 2016 | 62.36% |
| March 31, 2016 | 83.41% |
| December 31, 2015 | 80.37% |
| September 30, 2015 | 83.68% |
| June 30, 2015 | 83.91% |
| March 31, 2015 | 85.37% |
| December 31, 2014 | 82.54% |
| September 30, 2014 | 82.39% |
| June 30, 2014 | 68.15% |
| March 31, 2014 | 75.94% |
| December 31, 2013 | 74.52% |
| September 30, 2013 | 65.42% |
| June 30, 2013 | 64.71% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
44.36%
Minimum
Dec 2021
71.24%
Maximum
Jun 2019
59.22%
Average
60.76%
Median
Sep 2022
Gross Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | 42.06% |
| Ligand Pharmaceuticals Inc | 94.16% |
| Dentsply Sirona Inc | 51.58% |
| Allogene Therapeutics Inc | -- |
| Vanda Pharmaceuticals Inc | 92.36% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.64% |
| Return on Assets | 2.25% |
| Return on Invested Capital | 2.72% |
| Profit Margin (Quarterly) | 0.88% |
| Operating Margin (Quarterly) | 6.62% |
| Return on Net Operating Assets | 3.23% |